DRG Epidemiology’s coverage of genitourinary syndrome of menopause (GSM) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan). We report the prevalence of GSM for each country, as well as annualized case counts projected to the national population.

Patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets covered in this report.

DRG Epidemiology’s GSM forecast will answer the following questions:

  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of GSM over the forecast period?

All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.

In addition to the total number of cases for each forecast year, DRG Epidemiology provides at least ten years of forecast data for the following genitourinary syndrome of menopause subpopulations:

  • Concurrent symptoms.

Note: Coverage may vary by country.

Table of contents

  • Genitourinary Syndrome Of Menopause - Epidemiology - Mature Markets Data
    • Introduction
      • Key Findings
      • Total Prevalence of Genitourinary Syndrome of Menopause per 100 Women Aged 45 or Older in 2018 and 2038
      • Relative Sizes of the Contributing Factors to the Trend in Total Prevalent Cases of Genitourinary Syndrome of Menopause over the Next 20 Years
    • Epidemiology Data
    • Methods
      • Total Prevalent Cases
      • Concurrent Symptoms
    • Reference Materials
      • Literature Review
        • Studies Included in the Analysis of Genitourinary Syndrome of Menopause
        • Studies Excluded from the Analysis of Genitourinary Syndrome of Menopause
      • Risk/Protective Factors
        • Risk/Protective Factors for Genitourinary Syndrome of Menopause
      • Bibliography

Author(s): Ema Rodrigues, DSc, MPH

Ema is an epidemiologist with expertise in forecasting incident and prevalent populations within oncology, as well as some cardiovascular indications such as venous thromboembolism. She has significant experience with statistical methods such as multivariate linear regression, conditional logistic regression, principal components analysis, mixed models, hierarchical modeling, and path analysis to account for the complex relationships among various predictors of health outcomes, particularly correlated variables.

She completed her master’s and doctoral degree (MPH, D.Sc.) in Environmental Health at Boston University School of Public Health, where she worked on projects investigating significant predictors of various health outcomes including central nervous system cancer, cognitive function, and birth outcomes.